Paula Gergen
Lawyers
Filters
Olema Pharmaceuticals $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Mirion Technologies $85.6 million secondary offering
The offering consists of 9,786,153 shares of Class A common stock
Ardelyx $150 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Mirion Technologies $150 million registered direct offering
We advised Mirion on the offering
RxSight $50 million follow-on offering
The stock is listed on the Nasdaq Global Market
Coherus BioSciences $150 million at-the-market offering
The stock is listed on the Nasdaq Global Market
RAPT Therapeutics $75 million follow-on offering
The shares are listed on the Nasdaq Global Market
Denali Therapeutics $316 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
EDAP TMS $23 million follow-on offering
The ADSs are listed on the Nasdaq Global Market
SVB Financial $2.25 billion concurrent offerings of notes and preferred stock
The company issued senior notes due 2026 and depositary shares representing Series D and Series E perpetual preferred stock